Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 20
1.
J Affect Disord ; 356: 346-355, 2024 Jul 01.
Article En | MEDLINE | ID: mdl-38626809

BACKGROUND: The association between frailty and psychiatric disorders has been reported in observational studies. However, it is unclear whether frailty facilitates the appearance of psychiatric disorders or vice versa. Therefore, we conducted a bidirectional Mendelian randomization (MR) study to evaluate the causality. METHODS: Independent genetic variants associated with frailty index (FI) and psychiatric disorders were obtained from large genome-wide association studies (GWAS). The inverse variance weighted method was utilized as the primary method to estimate causal effects, followed by various sensitivity analyses. Multivariable analyses were performed to further adjust for potential confounders. RESULTS: The present MR study revealed that genetically predicted FI was significantly and positively associated with the risk of major depressive disorder (MDD) (odds ratio [OR] 1.79, 95 % confidence interval [CI] 1.48-2.15, P = 1.06 × 10-9), anxiety disorder (OR 1.61, 95 % CI 1.19-2.18, P = 0.002) and neuroticism (OR 1.38, 95 % CI 1.18-1.61, P = 3.73 × 10-5). In the reverse MR test, genetic liability to MDD (beta 0.232, 95 % CI 0.189-0.274, P = 1.00 × 10-26) and neuroticism (beta 0.128, 95 % CI 0.081-0.175, P = 8.61 × 10-8) were significantly associated with higher FI. Multivariable analyses results supported the causal association between FI and MDD and neuroticism. LIMITATIONS: Restriction to European populations, and sample selection bias. CONCLUSIONS: Our study suggested a bidirectional causal association between frailty and MDD neuroticism, and a positive correlation of genetically predicted frailty on the risk of anxiety disorder. Developing a deeper understanding of these associations is essential to effectively manage frailty and optimize mental health in older adults.


Anxiety Disorders , Depressive Disorder, Major , Frailty , Genome-Wide Association Study , Mendelian Randomization Analysis , Neuroticism , Humans , Frailty/genetics , Frailty/epidemiology , Depressive Disorder, Major/genetics , Depressive Disorder, Major/epidemiology , Anxiety Disorders/genetics , Anxiety Disorders/epidemiology , Mental Disorders/genetics , Mental Disorders/epidemiology , Male , Aged , Female , Genetic Predisposition to Disease/genetics , Polymorphism, Single Nucleotide
2.
Pediatr Surg Int ; 40(1): 38, 2024 Jan 22.
Article En | MEDLINE | ID: mdl-38253735

PURPOSE: Hirschsprung's disease (HSCR) is the leading cause of neonatal functional intestinal obstruction, which has been identified in many familial cases. HSCR, a multifactorial disorder of enteric nervous system (ENS) development, is associated with at least 24 genes and seven chromosomal loci, with RET and EDNRB as its major genes. We present a genetic investigation of familial HSCR to clarify the genotype-phenotype relationship. METHODS: We performed whole exome sequencing (WES) on Illumina HiSeq X Ten platform to investigate genetic backgrounds of core family members, and identified the possibly harmful mutation genes. Mutation carriers and pedigree relatives were validated by Sanger sequencing for evaluating the gene penetrance. RESULTS: Four familial cases showed potential disease-relative variants in EDNRB and RET gene, accounting for all detection rate of 57.1%. Three familial cases exhibited strong pathogenic variants as frameshift or missense mutations in EDNRB gene. A novel c.367delinsTT mutation of EDNRB was identified in one family member. The other two EDNRB mutations, c.553G>A in family 2 and c.877delinsTT in family 5, have been reported in previous literatures. The penetrance of EDNRB variants was 33-50% according mutation carries. In family 6, the RET c.1858T>C (C620R) point mutation has previously been reported to cause HSCR, with 28.5% penetrance. CONCLUSION: We identified a novel EDNRB (deleted C and inserted TT) mutation in this study using WES. Heterozygote variations in EDNRB gene were significantly enriched in three families and RET mutations were identified in one family. EDNRB variants showed an overall higher incidence and penetrance than RET in southern Chinese families cases.


Hirschsprung Disease , Intestinal Obstruction , Receptor, Endothelin B , Humans , Infant, Newborn , China/epidemiology , Hirschsprung Disease/genetics , Incidence , Mutation , Receptor, Endothelin B/genetics
3.
Anal Chem ; 95(8): 4131-4137, 2023 02 28.
Article En | MEDLINE | ID: mdl-36799666

A novel ultrasensitive electrochemiluminescence (ECL) biosensor was constructed using two-dimensional (2D) Co3O4 nanosheets as a novel coreaction accelerator of the luminol/H2O2 ECL system for the detection of microRNA-21 (miRNA-21). Impressively, coreaction accelerator 2D Co3O4 nanosheets with effective mutual conversion of the Co2+/Co3+ redox pair and abundant active sites could promote the decomposition of coreactant H2O2 to generate more superoxide anion radicals (O2•-), which reacted with luminol for significantly enhancing ECL signals. Furthermore, the trace target miRNA-21 was transformed into a large number of G-wires through the strand displacement amplification (SDA) process to self-assemble the highly ordered rolling DNA nanomachine (HORDNM), which could tremendously improve the detection sensitivity of biosensors. Hence, on the basis of the novel luminol/H2O2/2D Co3O4 nanosheet ternary ECL system, the biosensor implemented ultrasensitive detection of miRNA-21 with a detection limit as low as 4.1 aM, which provided a novel strategy to design an effective ECL emitter for ultrasensitive detection of biomarkers for early disease diagnosis.


Biosensing Techniques , MicroRNAs , MicroRNAs/chemistry , Luminol/chemistry , Hydrogen Peroxide , Luminescent Measurements/methods , Electrochemical Techniques/methods , DNA/chemistry , Biosensing Techniques/methods , Limit of Detection
5.
J Pediatr Surg ; 55(11): 2403-2407, 2020 Nov.
Article En | MEDLINE | ID: mdl-32571537

BACKGROUND: Enhanced recovery after surgery (ERAS) has been widely used in adult surgery. However, ERAS has not been reported in neonatal surgery. The present prospective study explored the application value of ERAS in treating congenital duodenal obstruction (CDO). METHODS: A total of 68 cases of CDO were collected from October 1, 2017 to July 31, 2019. We divided patients with a prenatal diagnosis of congenital duodenal obstruction into the ERAS group and those who were diagnosed the disease after birth into the control group. The ERAS group adopted ERAS-related measures, and the control group followed the usual measures. The study compared the differences in the gestational age, birth weight, length of hospital stay (LOS), complications, feeding intolerance, and weight one month after surgery between the two groups. RESULTS: A total of 49 patients were included in the analysis, including 23 who were allocated to the ERAS group and 26 to the control group. The LOS was 9.696±1.222 days in the ERAS group and 12.654±1.686 days in the control group, resulting in a significantly shorter LOS in the ERAS group than in the control group (p<0.001). One month after surgery, the neonates in the ERAS group weighted significantly more than those in the control group. No differences were observed in birth weight, gestational age, and the incidence of complications or feeding intolerance between the two groups. CONCLUSION: In this single-center study, the implementation of neonate-specific ERAS for CDO surgery was feasible and safe and led to a shorter LOS without increasing the incidence of complications or feeding intolerance. TYPE OF STUDY: Treatment Study LEVEL OF EVIDENCE: Level III.


Duodenal Obstruction , Enhanced Recovery After Surgery , Duodenal Obstruction/congenital , Duodenal Obstruction/surgery , Female , Humans , Infant, Newborn , Length of Stay , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Pregnancy , Prospective Studies , Retrospective Studies
8.
J Pediatr Surg ; 53(9): 1716-1721, 2018 Sep.
Article En | MEDLINE | ID: mdl-29605259

BACKGROUND: Hirschsprung disease (HD) is a congenital intestinal anomaly resulting from a failure to form enteric ganglia in the lower bowel. Surgery is the main therapeutic strategy, although neural stem cell transplantation has recently shown promise. However, HD remains a challenging disorder to treat. Our aim was to identify drugs that could counteract the dysregulated pathways in HD and could thus be potential novel therapies. METHODS: We used microarray analysis to identify genes differentially expressed in ganglionic and aganglionic bowel samples from eight children with HD. The signature of differentially expressed genes was then used as a search query to explore the Connectivity Map (cMAP), a transcriptional expression database that catalogs gene signatures elicited by chemical perturbagens. RESULTS: We uncovered several dysregulated signaling pathways, and in particular regulation of neuron development, in HD. The cMAP search identified some compounds with the potential to counteract the effects of the dysregulated molecular signature in this disease. One of these, pepstatin A, was recently shown to rescue the migration defects observed in a mouse model of HD, providing strong support for our findings. CONCLUSIONS: This study advances our understanding of the molecular changes in HD and identifies several potential pharmacological interventions. Further testing of the identified compounds is warranted.


Data Mining , Databases, Genetic , Gastrointestinal Agents/therapeutic use , Gene Expression Profiling , Hirschsprung Disease/genetics , Oligonucleotide Array Sequence Analysis , Transcriptome , Female , Genetic Markers , Hirschsprung Disease/drug therapy , Humans , Infant , Male , RNA/analysis
10.
Med Sci Monit ; 23: 1552-1558, 2017 Mar 31.
Article En | MEDLINE | ID: mdl-28362720

BACKGROUND The aim of this study was to evaluate the value of semiquantitative analysis (SQA) of 99mTc-MIBI imaging in predicting early-stage cervical lymph node metastasis (CLNM) in thyroid carcinoma (TC). MATERIAL AND METHODS TC patients (n =106) undergoing surgical resection and histopathological examination were enrolled. All patients received 99mTc-MIBI imaging prior to surgery. P-glycoprotein (P-gp) expression was detected by PT-PCR and immunohistochemistry. With pathological results as the criterion standard, the diagnostic efficiency of 99mTc-MIBI imaging in predicting early-stage CLNM was evaluated. The correlation of P-gp with 99mTc-MIBI imaging was investigated. Logistic regression analysis was applied for analyzing the factors affecting early-stage CLNM. RESULTS The detection rate and misdiagnosis rate of 99mTc-MIBI imaging for early-stage CLNM diagnosis were 87.3% and 12.7%, respectively. Receiver operating characteristic (ROC) curve analysis showed an accuracy of 99mTc-MIBI imaging of 85.85%. Preoperative 99mTc-MIBI scan showed statistical differences between metastasis and non-metastasis groups in early and delayed T/NT and washout rate (all P<0.05). The percentage of P-gp-expressing cells and the expression rate of P-gp gene both exhibited statistical differences between metastasis and no-metastasis groups (both P<0.05). Tumor diameter, lesion distribution, the percentage of P-gp-expressing cells, and the expression rate of P-gp gene were risk factors for CLNM (all P<0.05). CONCLUSIONS 99mTc-MIBI imaging has value in qualitative diagnosis of early-stage CLNM in TC. Tumor diameter, lesion distribution, the percentage of P-gp-expressing cells, and the expression rate of P-gp gene were risk factors for CLNM.


Lymph Nodes/diagnostic imaging , Radiopharmaceuticals , Technetium Tc 99m Sestamibi , Thyroid Neoplasms/diagnostic imaging , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Adult , Aged , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Predictive Value of Tests , Prognosis , Radionuclide Imaging , Thyroid Neoplasms/pathology
11.
Life Sci ; 137: 56-64, 2015 Sep 15.
Article En | MEDLINE | ID: mdl-26209140

AIMS: Asiaticoside (AS) is a saponin monomer extracted from the medicinal plant Centella asiatica, which has a variety of biological effects. We intended to investigate the effects of asiaticoside on a hypoxia-induced pulmonary hypertension (HPH) rat model and examine the possible effects of asiaticoside on TGF-ß1/Smad signaling in vivo and in vitro. MAIN METHODS: The rat HPH model was established by hypoxic exposure and asiaticoside was administered for four weeks. Parameters including the mean pulmonary artery pressure (mPAP), the right ventricular hypertrophy (RVH) and the percentage of medial wall thickness were used to evaluate the development of HPH. TGF-ß1, TGF-ß receptor, Smad2/3 and phospho-Smad2/3 expressions were detected and the proliferation, migration and apoptosis of pulmonary arterial smooth muscle cells (PASMCs) adjusted by asiaticoside under the hypoxic condition were evaluated. KEY FINDINGS: Our data indicate that asiaticoside attenuated pulmonary hypertension, pulmonary vascular remodeling and RV hypertrophy in HPH rats, which was probably mediated by restraining the hypoxia-induced overactive TGF-ß1/Smad2/3 signaling and inhibiting the proliferation by inducing apoptosis of the PASMCs. SIGNIFICANCE: Given the preventative potential in animal models and in vitro, we propose asiaticoside as a promising protective treatment in HPH.


Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/prevention & control , Hypoxia/drug therapy , Signal Transduction/drug effects , Smad3 Protein/metabolism , Transforming Growth Factor beta1/metabolism , Triterpenes/pharmacology , Triterpenes/therapeutic use , Animals , Apoptosis/drug effects , Blood Pressure/drug effects , Blood Pressure/physiology , Caspase 3/metabolism , Cell Movement/drug effects , Cell Proliferation/drug effects , Disease Progression , Heart Ventricles/drug effects , Heart Ventricles/pathology , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/physiopathology , Hypertrophy/drug therapy , Hypoxia/complications , Hypoxia/pathology , Hypoxia/physiopathology , Male , Phosphorylation/drug effects , Pulmonary Artery/drug effects , Pulmonary Artery/metabolism , Rats , Receptors, Transforming Growth Factor beta/biosynthesis , Smad2 Protein/biosynthesis , Vascular Remodeling/drug effects , Vascular Remodeling/physiology
12.
Surg Radiol Anat ; 37(10): 1251-6, 2015 Dec.
Article En | MEDLINE | ID: mdl-26077024

BACKGROUND: Communicating bronchopulmonary foregut malformation (CBPFM) type IA is extremely rare and is associated with a high mortality rate. This malformation manifests with communication between the lung and the foregut, and this can lead to esophageal atresia and tracheoesophageal fistula (EA-TEF) to the distal pouch. PURPOSE: To detail radiographic findings of CBPFM type IA cases and to summarize an appropriate therapeutic strategy for the management of this disorder. METHODS: Medical data for two patients with CBPFM type IA were retrospectively reviewed with regard to radiographic characteristics, therapy, and outcome. RESULTS: Both cases were initially misdiagnosed due to the presence of EA-TEF. Unusual atelectasis of the lateral lung was observed in chest radiographs, while non-aerated hypoplastic right lung and agenesis of the right main bronchus were detected by computed tomography. A final diagnosis was made by esophagogram. Only one patient survived following surgery. CONCLUSION: CBPFM type IA is a rare condition and is extremely difficult to diagnose. However, CBPFM type IA should be suspected in patients manifesting EA and atelectasis of a unilateral lung on a chest radiograph. The decision to perform a pneumonectomy or bronchoplasty depends on the degree of exiting permitted due to pulmonary damage assessed by computed tomography.


Bronchi/abnormalities , Bronchography , Esophageal Atresia/diagnostic imaging , Lung/abnormalities , Lung/diagnostic imaging , Tracheoesophageal Fistula/diagnostic imaging , Bronchi/surgery , Esophageal Atresia/surgery , Fatal Outcome , Humans , Infant, Newborn , Lung/surgery , Male , Retrospective Studies , Tomography, X-Ray Computed , Tracheoesophageal Fistula/surgery
13.
J Res Med Sci ; 20(4): 416-9, 2015 Apr.
Article En | MEDLINE | ID: mdl-26110001

Fanconi syndrome results from a generalized abnormality of the proximal tubules of the kidney and owing to phosphate depletion can cause hypophosphatemic osteomalacia. Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus replication but exhibits nephrotoxicity when administered at a low dosage. We report two cases of Fanconi syndrome induced by ADV at 10 mg/day to call for regular screening for evidence of proximal tubular dysfunction and detailed bone metabolic investigations for prompt detection of ADV nephrotoxicity is critically important to ensure timely drug withdrawal before the development of irreversible tubulointerstitial injury.

15.
Int J Clin Exp Pathol ; 7(12): 8602-8, 2014.
Article En | MEDLINE | ID: mdl-25674224

Prostatic acid phosphatase (PAP) is expressed in nociceptive dorsal root ganglion (DRG) neurons and functions as an ectonucleotidase that dephosphorylates extracellular adenosine monophosphate (AMP) to adenosine to suppress pain via activating A1-adenosine receptor (A1R) in dorsal spinal cord. However, the effect of peripheral nerve injury on the expression of PAP has not been reported until now. In the present study we found that PAP expression in DRG neurons is significantly decreased from the 2nd day after peripheral nerve injury and reaches the bottom at the 14th. In addition, intrathecal PAP injection can reduce mechanical allodynia induced by spared nerve injury. Our findings suggest that the decrease of PAP is involved in pathophysiological mechanisms of neuropathic pain.


Acid Phosphatase/biosynthesis , Neuralgia/enzymology , Sensory Receptor Cells/enzymology , Animals , Down-Regulation , Ganglia, Spinal/enzymology , Hyperalgesia/metabolism , Immunohistochemistry , In Situ Hybridization , Male , Peripheral Nerve Injuries/enzymology , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction
16.
J Pediatr Surg ; 48(11): 2281-8, 2013 Nov.
Article En | MEDLINE | ID: mdl-24210200

OBJECTIVE: To study the differential expression of genes between Hirschsprung's disease (HSCR) and normal tissue by using microarray for exploring the mechanism of HSCR development and establishing the gene expression profiles of HSCR. METHODS: Colon tissues (aganglionic and normal segments) of 4 patients with HSCR were detected by the Agilent SurePrint G3 Human GE 8x60K Microarrays. RT-PCR was used to verify the results of Microarray test. Then, immunohistochemistry was used to demonstrate the expression of HAND2 in the myenteric plexus of the colon from 46 patients with HSCR to further explore the relationship between HAND2 and development of HSCR. RESULTS: A total of 12,125 meaningful expressed genes were screened out. 4 pairs of specimens had 622 differentially expressed genes, 584 (93.89%) of which were up-regulated while 38(6.11%) were down-regulated. 6 of the 622 genes were tested by RT-PCR, which were consistent with the results detected by Microarray. The average optical density of positive expression of HAND2 in myenteric plexus was compared between the aganglionic, transitional, dilated, normal segments and control group. The average optical density in the aganglionic segments was obviously reduced. Statistical analyzed data showed that it has significant deviation (P<0.01). CONCLUSION: 1. A set of differentially expressed genes between aganglionic and normal segments of HSCR was obtained. Our data may provide significant information to research the pathogenesis of HSCR. 2. Reduced protein expression of HAND2 in the myenteric plexus of the aganglionic would suggest that HAND2 was involved in the pathogenesis of HSCR.


Gene Expression Profiling/methods , Hirschsprung Disease/genetics , Oligonucleotide Array Sequence Analysis , Basic Helix-Loop-Helix Transcription Factors/biosynthesis , Basic Helix-Loop-Helix Transcription Factors/genetics , Colon/metabolism , Female , Genetic Association Studies , Humans , Immunohistochemistry , Infant , Male , Myenteric Plexus/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Receptors, Neurotensin/biosynthesis , Receptors, Neurotensin/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tubulin/biosynthesis , Tubulin/genetics
17.
Article Zh | MEDLINE | ID: mdl-23687831

According to "The Scheme of Schistosomiasis Surveillance in Zhejiang Province", the status of Oncomelania snails, and the schistosome infection of permanent residents, floating population, and livestock were surveyed in a provincial surveillance site of Shengzhou City, from 2008 to 2011. In 4 years, the area with residual snails was 3,060 m2, and no infected snails were found among 595 living snails. The positive rate of sero-tests for schistosomiasis of the permanent residents was 0.77%, and that of the floating population was 1.09%. No schistosomiasis cases were found. In conclusion, the area with residual snails is small and its distribution is scattered, and we still should strengthen the surveillance of snail status and imported schistosomiasis cases.


Cities/epidemiology , Epidemics/statistics & numerical data , Epidemiological Monitoring , Schistosomiasis/epidemiology , Adolescent , Adult , Animals , Cattle , Child , China/epidemiology , Communicable Disease Control/statistics & numerical data , Disease Vectors , Epidemics/prevention & control , Housing/statistics & numerical data , Human Migration/statistics & numerical data , Humans , Schistosomiasis/prevention & control , Schistosomiasis/transmission , Snails/parasitology , Snails/physiology , Young Adult
18.
Rheumatol Int ; 33(10): 2455-8, 2013 Oct.
Article En | MEDLINE | ID: mdl-23715693

This retrospective study assessed the efficacy of infliximab therapy in 14 patients with dermatomyositis with acute interstitial pneumonia. Ten patients starting treatment at an early stage of the disease achieved satisfactory relief, while four patients treated at a late stage failed to respond to the treatment and died.


Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antibodies, Monoclonal/therapeutic use , Dermatologic Agents/therapeutic use , Dermatomyositis/drug therapy , Lung Diseases, Interstitial/drug therapy , Adult , Dermatomyositis/complications , Female , Humans , Infliximab , Lung Diseases, Interstitial/complications , Middle Aged , Treatment Outcome
19.
Zhonghua Nei Ke Za Zhi ; 43(8): 600-3, 2004 Aug.
Article Zh | MEDLINE | ID: mdl-15355666

OBJECTIVES: To investigate the clinical features, diagnostic methods, therapeutic approaches, outcomes and the alterations of peripheral lymphocyte subsets in cytomegalovirus (CMV) diseases. METHODS: From August 2000 to October 2002, 50 cases of CMV diseases were treated in Peking Union Medical College Hospital. The diagnosis were made by their symptoms and positive CMV pp65 antigen or/and CMV specific IgM. Of the 50 patients, 15 were male, and 35 female. Their age was (35.5 +/- 16.2) years. Their clinical data were collected, and their peripheral lymphocyte subsets were measured at the time when they were first diagnosed as CMV disease. The lymphocyte subsets of 51 healthy blood donors were tested as normal controls. The lymphocyte subsets were compared between those who had an immunocompromising underlying disease and those who had not. RESULTS: (1) CMV disease occurred in 39 patients who had immunocompromising underlying diseases, and in 11 patients who had not; (2) CMV disease caused various symptoms, most of them were nonspecific. Fever (100%), hematological abnormalities (96%) and abnormal liver function test (30%) were the most common manifestations. 3 cases of CMV retinitis were acquired immune deficiency syndrome patients with CD4+ T cell count less than 50/ microl; 2 patients developed multiple organ failure; (3) The positive rates of CMV pp65 antigen and specific IgM assays were 85.3% and 68.3%, respectively; (4) Comparing with normal controls, all patients with CMV disease had decreased B cell and nature killer cells, increased CD8+ T cell percentage and a reversed CD4+/CD8+ ratio; further more, the patients with underlying diseases had lower CD4+ T-cell and CD8+ T-cell counts than those without underlying diseases. CONCLUSIONS: CMV disease occurred in patients with or without underlying diseases. Their clinical manifestations were heterogeneous and non-specific, therefore, special laboratory tests were necessary to confirm the diagnosis. pp65 antigen assay had more diagnostic value than IgM assay. The dramatic changes in lymphocyte subsets suggest CMV disease has a immunological pathogenesis.


Cytomegalovirus Infections/diagnosis , Cytomegalovirus/immunology , Adolescent , Adult , Aged , Antigens, Viral/blood , Child , Child, Preschool , Cytomegalovirus Infections/immunology , Female , Humans , Immunoglobulin M/blood , Infant , Lymphocyte Subsets/immunology , Male , Middle Aged , Phosphoproteins/blood , Viral Matrix Proteins/blood
20.
Yi Chuan ; 24(3): 305-9, 2002 May.
Article Zh | MEDLINE | ID: mdl-16126688

The cytogenetic toxic effects of different concentration of As2O3 within different time on the cell of Vicia Faba root tip were studied. The results indicate that the different concentrations of As2O3 can induce high frequency of micronucleus and chromosome aberration. Besides, it can accumulate the metaphases in mitosis efficiently and prevent the cells from continuing their cell cycle. It shows that As2O3 has marked cytogenetic toxic effect on the root tip cells of Vicia Faba, and effect of accumulating the metaphases in mitosis.

...